Protomer Technologies has taken the top prize in this year’s 2 Diabetes Innovation Challenge, worth $150k in the competition run by American-based T1D Exchange. The Challenge is a world-wide competition run by T1D Exchange to identify, nurture and fast-track innovative scientific and clinical solutions for diabetes.
This is a technology that could see a revolutionary ‘smart’ drug prevent hypoglycemia in people with diabetes in the form of a glucose-responsive glucagon. While it is still in development, this should be able sense low sugar levels while automatically activate to restore blood sugar levels to prevent unpleasant hypos.
“Every person with Type 1 diabetes who takes insulin lives in fear of hypoglycemia, and for some, it means they never quite achieve optimal insulin levels,” says Protomer Technologies Founder and CEO Alborz Mahdavi. “The visibility and exposure of winning the Diabetes Innovation Challenge, along with the first-place prize, will be invaluable in our efforts to bring this smart-drug technology to people with diabetes as soon as possible.”
News items and features like this appear in the Desang Diabetes Magazine, our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it’s free, and you can easily unsubscribe should you wish to).